Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionstructural constituent of skin epidermis

KRT81 KRT83 KRT84 KRT85 KRT86

6.52e-06431235GO:0030280
GeneOntologyMolecularFunctionRNA polymerase III cis-regulatory region sequence-specific DNA binding

GTF3C5 MTOR SNAPC4

7.84e-0671233GO:0000992
GeneOntologyMolecularFunctionRNA polymerase III transcription regulatory region sequence-specific DNA binding

GTF3C5 MTOR SNAPC4

1.25e-0581233GO:0001016
GeneOntologyMolecularFunctionRNA polymerase III general transcription initiation factor activity

GTF3C5 GTF3C3 SNAPC4

6.24e-05131233GO:0000995
GeneOntologyMolecularFunction5S rDNA binding

GTF3C5 MTOR

1.12e-0431232GO:0080084
GeneOntologyMolecularFunctionRNA polymerase III type 2 promoter sequence-specific DNA binding

GTF3C5 MTOR

1.12e-0431232GO:0001003
GeneOntologyMolecularFunctionRNA polymerase III type 1 promoter sequence-specific DNA binding

GTF3C5 MTOR

1.12e-0431232GO:0001002
GeneOntologyMolecularFunctionprotein serine kinase activity

HIPK3 CAMKK2 LATS2 MTOR ULK4 ATM PRKG1 MAP2K5 ULK2

4.19e-043631239GO:0106310
GeneOntologyMolecularFunctionprotein serine/threonine kinase activity

HJV HIPK3 CAMKK2 LATS2 MTOR ULK4 ATM PRKG1 MAP2K5 ULK2

4.43e-0444612310GO:0004674
GeneOntologyMolecularFunctionRNA polymerase III type 3 promoter sequence-specific DNA binding

MTOR SNAPC4

5.55e-0461232GO:0001006
GeneOntologyMolecularFunctionchromo shadow domain binding

ATRX NIPBL

5.55e-0461232GO:0070087
GeneOntologyMolecularFunctionprotein kinase activity

HJV IRAK2 HIPK3 CAMKK2 LATS2 MTOR ULK4 ATM PRKG1 MAP2K5 ULK2

1.21e-0360012311GO:0004672
GeneOntologyBiologicalProcessintermediate filament organization

KRT9 KRT14 KRT17 KRT81 KRT83 KRT84 KRT85 KRT86

1.18e-08751198GO:0045109
GeneOntologyBiologicalProcessintermediate filament cytoskeleton organization

KRT9 KRT14 KRT17 KRT81 KRT83 KRT84 KRT85 KRT86

1.07e-07991198GO:0045104
GeneOntologyBiologicalProcessintermediate filament-based process

KRT9 KRT14 KRT17 KRT81 KRT83 KRT84 KRT85 KRT86

1.16e-071001198GO:0045103
GeneOntologyBiologicalProcessskin development

KRT9 KRT14 KRT17 KRT81 ENPP1 KRT83 KRT84 KRT85 KRT86 DICER1 LATS2 SOS1

1.71e-0637311912GO:0043588
GeneOntologyBiologicalProcesskeratinization

KRT17 KRT81 KRT83 KRT84 KRT85 KRT86

1.12e-05871196GO:0031424
GeneOntologyBiologicalProcesskeratinocyte differentiation

KRT14 KRT17 KRT81 KRT83 KRT84 KRT85 KRT86 LATS2

1.41e-051891198GO:0030216
GeneOntologyBiologicalProcessmulticellular organism growth

OTOA ATRX ENPP1 DICER1 KMT2C MTOR ATM NIPBL SOS1

1.44e-052491199GO:0035264
GeneOntologyBiologicalProcessmolting cycle

KRT14 KRT17 KRT83 KRT84 DICER1 NIPBL SOS1

2.65e-051501197GO:0042303
GeneOntologyBiologicalProcesshair cycle

KRT14 KRT17 KRT83 KRT84 DICER1 NIPBL SOS1

2.65e-051501197GO:0042633
GeneOntologyBiologicalProcesstranscription by RNA polymerase III

POLR2E GTF3C5 GTF3C3 MTOR SNAPC4

3.16e-05631195GO:0006383
GeneOntologyBiologicalProcesstRNA transcription by RNA polymerase III

POLR2E GTF3C5 GTF3C3

3.97e-05121193GO:0042797
GeneOntologyBiologicalProcesstRNA transcription

POLR2E GTF3C5 GTF3C3

5.13e-05131193GO:0009304
GeneOntologyBiologicalProcessepidermis development

KRT9 KRT14 KRT17 KRT81 KRT83 KRT84 KRT85 KRT86 DICER1 LATS2 SOS1

7.44e-0546111911GO:0008544
GeneOntologyBiologicalProcesspost-embryonic forelimb morphogenesis

ATRX ENPP1

9.86e-0531192GO:0035128
GeneOntologyBiologicalProcesspost-embryonic development

ATRX SZT2 ENPP1 DICER1 MTOR ATM

1.33e-041351196GO:0009791
GeneOntologyBiologicalProcessrRNA transcription

POLR2E GTF3C5 GTF3C3 MTOR

1.43e-04461194GO:0009303
GeneOntologyBiologicalProcessoligodendrocyte differentiation

ENPP1 DICER1 PTPRJ MTOR ULK4 EXOC4

1.44e-041371196GO:0048709
GeneOntologyBiologicalProcessdevelopmental growth

OTOA ATRX ENPP1 SPG11 NCAPG2 DICER1 KMT2C SLC39A12 LATS2 MTOR ATM PRKG1 ULK2 NIPBL SOS1

2.40e-0491111915GO:0048589
GeneOntologyBiologicalProcessepidermal cell differentiation

KRT14 KRT17 KRT81 KRT83 KRT84 KRT85 KRT86 LATS2

2.45e-042841198GO:0009913
GeneOntologyBiologicalProcessgrowth

OTOA KRT17 ATRX ENPP1 SPG11 NCAPG2 DICER1 KMT2C SLC39A12 LATS2 PTPRJ MTOR ATM PRKG1 MAP2K5 ULK2 NIPBL SOS1

2.51e-04123511918GO:0040007
GeneOntologyBiologicalProcesspost-embryonic limb morphogenesis

ATRX ENPP1

3.26e-0451192GO:0035127
GeneOntologyBiologicalProcesspost-embryonic appendage morphogenesis

ATRX ENPP1

3.26e-0451192GO:0035120
GeneOntologyBiologicalProcessDNA repair

RNASEH2B ATRX RTEL1 USP44 MLH3 ABRAXAS1 KLHL15 TERB1 ATM ASCC3 NIPBL VCPIP1

3.70e-0464811912GO:0006281
GeneOntologyBiologicalProcesswalking behavior

KLHL1 ENPP1 SPG11 ULK4

4.00e-04601194GO:0090659
GeneOntologyCellularComponentkeratin filament

KRT9 KRT14 KRT17 KRT81 KRT83 KRT84 KRT85 KRT86

1.00e-07971228GO:0045095
GeneOntologyCellularComponentintermediate filament

KRT9 KRT14 KRT17 KRT81 KRT83 KRT84 KRT85 KRT86

5.69e-052271228GO:0005882
GeneOntologyCellularComponentpolymeric cytoskeletal fiber

KRT9 KRT14 KRT17 EFCAB6 KRT81 KRT83 KRT84 KRT85 KRT86 LRRC49 ARFGEF2 HOOK3 KIF15 DNAI2 CEP57 MX2

6.90e-0589912216GO:0099513
GeneOntologyCellularComponentintermediate filament cytoskeleton

KRT9 KRT14 KRT17 KRT81 KRT83 KRT84 KRT85 KRT86

1.58e-042631228GO:0045111
GeneOntologyCellularComponentintegrator complex

INTS13 INTS15 NIPBL

2.39e-04211223GO:0032039
GeneOntologyCellularComponentsupramolecular fiber

CAB39 KRT9 KRT14 KRT17 EFCAB6 KRT81 KRT83 KRT84 KRT85 KRT86 LRRC49 ARFGEF2 HOOK3 KIF15 DNAI2 CEP57 MX2

4.95e-04117912217GO:0099512
GeneOntologyCellularComponenttranscription factor TFIIIC complex

GTF3C5 GTF3C3

4.99e-0461222GO:0000127
GeneOntologyCellularComponentsupramolecular polymer

CAB39 KRT9 KRT14 KRT17 EFCAB6 KRT81 KRT83 KRT84 KRT85 KRT86 LRRC49 ARFGEF2 HOOK3 KIF15 DNAI2 CEP57 MX2

5.34e-04118712217GO:0099081
GeneOntologyCellularComponentRNA polymerase III transcription regulator complex

GTF3C5 GTF3C3

1.18e-0391222GO:0090576
HumanPhenoPerifollicular hyperkeratosis

KRT81 KRT83 KRT86

5.00e-064563HP:0007468
HumanPhenoAbnormal perifollicular morphology

KRT81 KRT83 KRT86

2.46e-056563HP:0031285
HumanPhenoPalmoplantar hyperkeratosis

KRT9 KRT14 KRT17 RTEL1 ENPP1 KRT83 KRT85 AP1B1

6.96e-05129568HP:0000972
HumanPhenoPalmar hyperkeratosis

KRT9 KRT14 KRT17 RTEL1 ENPP1 KRT83 KRT85 AP1B1

7.76e-05131568HP:0010765
HumanPhenoPlantar hyperkeratosis

KRT9 KRT14 KRT17 RTEL1 ENPP1 KRT83 KRT85 AP1B1

8.20e-05132568HP:0007556
HumanPhenoAbnormality of the plantar skin of foot

KRT9 KRT14 KRT17 RTEL1 ENPP1 KRT83 KRT85 AP1B1 MTOR

8.53e-05171569HP:0100872
MousePhenoabnormal cell nucleus morphology

KRT17 RTEL1 USP44 LATS2 ABRAXAS1 ATM CEP57 NIPBL VCPIP1

5.61e-06184989MP:0003111
MousePhenoabnormal chromosome morphology

RTEL1 USP44 LATS2 ATM CEP57 NIPBL VCPIP1

2.87e-05126987MP:0003702
DomainARM-type_fold

IPO5 CAB39 IPO8 IPO7 ARMC3 UBR4 MROH5 ARFGEF2 PSMD1 NCAPG2 AP1B1 AP2B1 MTOR LTN1 TERB1 ULK4 ATM NIPBL TARBP1

6.49e-1333912119IPR016024
DomainARM-like

IPO5 CAB39 IPO8 IPO7 ARMC3 MROH5 ARFGEF2 PSMD1 NCAPG2 AP1B1 AP2B1 MTOR LTN1 TERB1 ULK4 NIPBL TARBP1

1.83e-1227012117IPR011989
Domain-

IPO5 CAB39 IPO8 IPO7 ARMC3 MROH5 ARFGEF2 PSMD1 NCAPG2 AP1B1 AP2B1 MTOR TERB1 ULK4 NIPBL

1.48e-11222121151.25.10.10
DomainIntermediate_filament_CS

KRT9 KRT14 KRT17 KRT81 KRT83 KRT84 KRT85 KRT86

7.06e-09631218IPR018039
DomainFilament

KRT9 KRT14 KRT17 KRT81 KRT83 KRT84 KRT85 KRT86

1.86e-08711218SM01391
DomainIF

KRT9 KRT14 KRT17 KRT81 KRT83 KRT84 KRT85 KRT86

2.08e-08721218PS00226
DomainFilament

KRT9 KRT14 KRT17 KRT81 KRT83 KRT84 KRT85 KRT86

2.32e-08731218PF00038
DomainIF

KRT9 KRT14 KRT17 KRT81 KRT83 KRT84 KRT85 KRT86

3.21e-08761218IPR001664
DomainKeratin_2_head

KRT81 KRT83 KRT84 KRT85 KRT86

4.04e-07241215IPR032444
DomainKeratin_2_head

KRT81 KRT83 KRT84 KRT85 KRT86

4.04e-07241215PF16208
DomainKeratin_II

KRT81 KRT83 KRT84 KRT85 KRT86

6.20e-07261215IPR003054
DomainClathrin_b-adaptin_app_Ig-like

AP1B1 AP2B1

4.16e-0521212IPR013037
Domain-

AP1B1 AP2B1

4.16e-05212122.60.40.1150
DomainHEAT_REPEAT

IPO5 NCAPG2 MTOR ULK4 NIPBL

9.08e-05701215PS50077
DomainIMPORTIN_B_NT

IPO5 IPO8 IPO7

9.16e-05141213PS50166
DomainAP_complex_bsu_1_2_4

AP1B1 AP2B1

1.24e-0431212IPR016342
DomainCse1

IPO8 IPO7

1.24e-0431212PF08506
DomainCse1

IPO8 IPO7

1.24e-0431212IPR013713
DomainB2-adapt-app_C

AP1B1 AP2B1

1.24e-0431212PF09066
DomainImportin-beta_N

IPO5 IPO8 IPO7

1.69e-04171213IPR001494
DomainKeratin_I

KRT9 KRT14 KRT17 KRT84

1.86e-04441214IPR002957
DomainB2-adapt-app_C

AP1B1 AP2B1

2.48e-0441212SM01020
DomainB-adaptin_app_sub_C

AP1B1 AP2B1

2.48e-0441212IPR015151
DomainAP_beta

AP1B1 AP2B1

4.11e-0451212IPR026739
DomainFATC

MTOR ATM

4.11e-0451212PF02260
DomainHEAT

IPO5 NCAPG2 MTOR NIPBL

5.43e-04581214IPR000357
DomainFAT

MTOR ATM

6.14e-0461212PS51189
DomainFATC

MTOR ATM

6.14e-0461212PS51190
DomainFAT

MTOR ATM

6.14e-0461212PF02259
DomainPIK-rel_kinase_FAT

MTOR ATM

6.14e-0461212IPR003151
DomainFATC_dom

MTOR ATM

6.14e-0461212IPR003152
DomainPIK_FAT

MTOR ATM

6.14e-0461212IPR014009
DomainBeta2_adaptin/TBP_C_dom

AP1B1 AP2B1

6.14e-0461212IPR012295
DomainFATC

MTOR ATM

6.14e-0461212SM01343
Domain-

AP1B1 AP2B1

6.14e-04612123.30.310.10
DomainKinase-like_dom

IRAK2 HIPK3 CAMKK2 LATS2 MTOR ULK4 ATM PRKG1 MAP2K5 ULK2 SOS1

7.98e-0454212111IPR011009
DomainCoatomer/calthrin_app_sub_C

AP1B1 AP2B1

1.14e-0381212IPR009028
DomainAlpha_adaptinC2

AP1B1 AP2B1

1.45e-0391212PF02883
DomainClathrin_a/b/g-adaptin_app_Ig

AP1B1 AP2B1

1.45e-0391212IPR008152
DomainAlpha_adaptinC2

AP1B1 AP2B1

1.45e-0391212SM00809
DomainARM

ARMC3 AP1B1 AP2B1

2.20e-03401213SM00185
DomainPROTEIN_KINASE_ST

IRAK2 HIPK3 CAMKK2 LATS2 ULK4 PRKG1 MAP2K5 ULK2

2.48e-033621218PS00108
DomainCoatomer/clathrin_app_Ig-like

AP1B1 AP2B1

2.63e-03121212IPR013041
DomainPkinase

IRAK2 HIPK3 CAMKK2 LATS2 ULK4 PRKG1 MAP2K5 ULK2

3.39e-033811218PF00069
DomainArmadillo

ARMC3 AP1B1 AP2B1

3.49e-03471213IPR000225
DomainClathrin/coatomer_adapt-like_N

AP1B1 AP2B1

4.14e-03151212IPR002553
DomainPI3/4_kinase_CS

MTOR ATM

4.14e-03151212IPR018936
DomainAdaptin_N

AP1B1 AP2B1

4.14e-03151212PF01602
DomainIBN_N

IPO8 IPO7

4.14e-03151212PF03810
Domain-

MTOR ATM

4.71e-031612121.10.1070.11
DomainIBN_N

IPO8 IPO7

4.71e-03161212SM00913
DomainPI3Kc

MTOR ATM

4.71e-03161212SM00146
DomainPI3_PI4_kinase

MTOR ATM

5.95e-03181212PF00454
DomainPI3_4_KINASE_1

MTOR ATM

5.95e-03181212PS00915
DomainPI3_4_KINASE_2

MTOR ATM

5.95e-03181212PS00916
DomainPI3/4_kinase_cat_dom

MTOR ATM

5.95e-03181212IPR000403
DomainPI3_4_KINASE_3

MTOR ATM

5.95e-03181212PS50290
PathwayREACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE

KRT9 KRT14 KRT17 KRT81 KRT83 KRT84 KRT85 KRT86

7.13e-0887898MM15351
PathwayREACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE

KRT9 KRT14 KRT17 KRT81 KRT83 KRT84 KRT85 KRT86

1.50e-06129898M27649
PathwayREACTOME_KERATINIZATION

KRT9 KRT14 KRT17 KRT81 KRT83 KRT84 KRT85 KRT86

5.38e-06153898MM15343
PathwayREACTOME_RNA_POLYMERASE_III_TRANSCRIPTION

POLR2E GTF3C5 GTF3C3 SNAPC4

5.96e-0534894MM15435
PathwayREACTOME_KERATINIZATION

KRT9 KRT14 KRT17 KRT81 KRT83 KRT84 KRT85 KRT86

6.71e-05217898M27640
PathwayREACTOME_RNA_POLYMERASE_III_TRANSCRIPTION

POLR2E GTF3C5 GTF3C3 SNAPC4

1.26e-0441894M739
Pubmed

New consensus nomenclature for mammalian keratins.

KRT9 KRT14 KRT17 KRT81 KRT83 KRT84 KRT85 KRT86

6.40e-1163123816831889
Pubmed

Charting the molecular network of the drug target Bcr-Abl.

KRT9 KRT14 KRT17 KRT81 KRT83 KRT84 KRT85 KRT86 UBR4 AP1B1 AP2B1 SOS1

2.12e-102661231219380743
Pubmed

Characterization of a 300 kbp region of human DNA containing the type II hair keratin gene domain.

KRT81 KRT83 KRT84 KRT85 KRT86

3.96e-1012123510692104
Pubmed

Characterization of the EGFR interactome reveals associated protein complex networks and intracellular receptor dynamics.

IPO5 IPO8 IPO7 KRT86 NCAPG2 AP2B1 MTOR LTN1 EXOC4 SOS1

1.14e-091831231023956138
Pubmed

Defining the human deubiquitinating enzyme interaction landscape.

IPO5 CUL2 KIAA0930 IPO7 KRT17 KRT81 KRT84 KRT85 POLR2E USP25 PSMD1 DICER1 USP44 AP2B1 ABRAXAS1 KLHL15 ASCC3 TARBP1 VCPIP1

2.75e-0910051231919615732
Pubmed

Novel KRT83 and KRT86 mutations associated with monilethrix.

KRT81 KRT83 KRT86

4.32e-083123325557232
Pubmed

Structure and site of expression of a murine type II hair keratin.

KRT81 KRT83 KRT86

4.32e-08312331372089
Pubmed

Transient expression of mouse hair keratins in transfected HeLa cells: interactions between "hard" and "soft" keratins.

KRT81 KRT83 KRT86

4.32e-08312331712823
Pubmed

Sequences and differential expression of three novel human type-II hair keratins.

KRT83 KRT85 KRT86

4.32e-08312339084137
Pubmed

LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.

IPO5 KRT9 KRT14 IPO7 ARFGEF2 DICER1 MTOR LTN1 ASCC3

4.68e-08202123933005030
Pubmed

Defining the membrane proteome of NK cells.

IPO5 ACAP1 KRT9 IPO7 LSG1 UBR4 ARFGEF2 PSMD1 ERGIC2 CCDC77 NCAPG2 KIF15 AP2B1 MTOR ENTPD1 EXOC2 ASCC3 EXOC4

1.63e-0711681231819946888
Pubmed

Characterization and chromosomal localization of human hair-specific keratin genes and comparative expression during the hair growth cycle.

KRT14 KRT81 KRT86

1.72e-07412339457912
Pubmed

Keratins of the human hair follicle.

KRT81 KRT83 KRT86

1.72e-074123315797458
Pubmed

ATM binds to beta-adaptin in cytoplasmic vesicles.

AP1B1 AP2B1 ATM

1.72e-07412339707615
Pubmed

Hague (Hag). A new mouse hair mutation with an unstable semidominant allele.

KRT81 KRT84 KRT85 KRT86

2.62e-0716123412399393
Pubmed

Deletion of the epidermis derived laminin γ1 chain leads to defects in the regulation of late hair morphogenesis.

KRT14 KRT81 KRT85 KRT86

5.54e-0719123427234308
Pubmed

A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.

IPO5 CUL2 TBC1D9B IPO8 IPO7 PPFIBP1 UBR4 POLR2E PSMD1 NCAPG2 DICER1 HOOK3 AP2B1 MTOR LTN1 ATM EXOC2 ASCC3 EXOC4

7.59e-0714401231930833792
Pubmed

A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.

IPO5 CUL2 IPO7 PSMD1 GTF3C5 THOC5 AP1B1 AP2B1 INTS13 LTN1 EXOC2 EXOC4

7.69e-075601231235241646
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

KRT14 KRT17 ATRX ARMC3 LSG1 KRT84 UBR4 SANBR PSMD1 SPG11 CCDC77 TNRC18 LATS2 AP2B1 ATM PLCH1 DTHD1 CEP57 NIPBL

7.74e-0714421231935575683
Pubmed

Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.

GCFC2 IPO8 PPFIBP1 UBR4 PSMD1 CCDC77 THOC5 WTAP KMT2C TNRC18 INTS15 POC5 TARBP1

1.08e-066891231336543142
Pubmed

Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.

CUL2 IPO8 IPO7 ATRX LSG1 PPFIBP1 UBR4 SPG11 FASTKD2 CCDC77 NCAPG2 DICER1 GTF3C3 THOC5 CAMKK2 ATM ASCC3 PLCH1 EXOC4

1.22e-0614871231933957083
Pubmed

Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.

ATRX RTEL1 CCDC77 NCAPG2 MLH3 AP1B1 AP2B1 NIPBL

1.33e-06222123837071664
Pubmed

Functional proteomics mapping of a human signaling pathway.

ATRX KRT81 UBR4 USP25 ARFGEF2 PSMD1 EPG5 HIPK3 RLF AP1B1 ASCC3 VCPIP1

1.35e-065911231215231748
Pubmed

Signal recognition particle protein 19 is imported into the nucleus by importin 8 (RanBP8) and transportin.

IPO5 IPO8 IPO7

1.50e-067123311682607
Pubmed

CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI.

ARFGEF2 NCAPG2 LTN1 ATM EXOC2 TARBP1

1.98e-06104123631240132
Pubmed

Importin 8 mediates m7G cap-sensitive nuclear import of the eukaryotic translation initiation factor eIF4E.

IPO5 IPO8 IPO7

2.39e-068123327114554
Pubmed

5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia.

IPO8 MTOR ATM EXOC2

2.45e-0627123423027611
Pubmed

Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.

LRRC49 UBR4 PSMD1 GTF3C5 GTF3C3 RLF KIF15 ASCC3 EXOC4 VCPIP1

2.53e-064181231034709266
Pubmed

The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.

IPO5 IPO8 IPO7 UBR4 PSMD1 GTF3C5 GTF3C3 AP1B1 AP2B1 MTOR ASCC3 EXOC4

2.96e-066381231233239621
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

IPO5 ATRX PPFIBP1 KRT83 UBR4 USP25 ARFGEF2 PSMD1 AP2B1 SH3D19 ATM RAPGEF2 NIPBL TARBP1 EXOC4 VCPIP1 SOS1

2.97e-0612851231735914814
Pubmed

Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.

CUL2 SAMD9 ATRX LSG1 ENPP1 PPFIBP1 ERGIC2 NCAPG2 DICER1 AP1B1 PLCH1 EXOC4

3.58e-066501231238777146
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

IPO5 IPO7 UBR4 PSMD1 DICER1 GTF3C3 AP1B1 AP2B1 MTOR ATM ASCC3 NIPBL

3.75e-066531231222586326
Pubmed

Network organization of the human autophagy system.

IPO5 CUL2 CAB39 ENPP1 KRT85 GTF3C3 CAMKK2 MTOR SNAPC4 ULK2

3.75e-064371231020562859
Pubmed

A high-throughput approach for measuring temporal changes in the interactome.

IPO5 RNASEH2B CUL2 IPO7 KRT17 UBR4 POLR2E USP25 ARFGEF2 PSMD1 NIF3L1 UNC13D KIF15 AP1B1 AP2B1 MTOR INTS13 VCPIP1

3.77e-0614551231822863883
Pubmed

Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.

IPO8 ATRX SZT2 LSG1 POTEG HIPK3 SLC39A12 AP1B1 ENTPD1 ULK4 IL17RD

4.53e-065521231110737800
Pubmed

ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.

IPO5 CUL2 KRT9 KRT14 IPO7 PSMD1 NCAPG2 AP1B1 AP2B1 INTS13

4.95e-064511231036168627
Pubmed

LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.

TBC1D9B IPO7 UBR4 POLR2E PSMD1 NCAPG2 GTF3C3 AP1B1 MTOR B3GNT2 ASCC3 TARBP1 EXOC4 VCPIP1

6.52e-069421231431073040
Pubmed

Ephrin-As, Eph receptors and integrin α3 interact and colocalise at membrane protrusions of U251MG glioblastoma cells.

KRT9 KRT14 KRT17 RTEL1 KRT83 KRT85 SOS1

6.86e-06197123723686814
Pubmed

Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.

IPO5 IPO7 ATRX ARFGEF2 PSMD1 AP1B1 INTS13 ATM EXOC2 NIPBL EXOC4

7.46e-065821231120467437
Pubmed

An Interaction Landscape of Ubiquitin Signaling.

CUL2 UBR4 USP25 PSMD1 ERGIC2 KIF15 AP2B1 ABRAXAS1 ASCC3 VCPIP1

8.69e-064811231028190767
Pubmed

VCP phosphorylation-dependent interaction partners prevent apoptosis in Helicobacter pylori-infected gastric epithelial cells.

CAB39 TBC1D9B UBR4 ARFGEF2 GTF3C5 GTF3C3 AP1B1 MTOR

9.07e-06288123823383273
Pubmed

LncRNA DUXAP9-206 directly binds with Cbl-b to augment EGFR signaling and promotes non-small cell lung cancer progression.

SAMD9 ULK4 ULK2

9.28e-0612123330515972
Pubmed

A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.

IPO5 CUL2 IPO8 IPO7 UBR4 PSMD1 NCAPG2 DICER1 AP1B1 AP2B1 MTOR LTN1 ASCC3 VCPIP1

9.49e-069741231428675297
Pubmed

A human MAP kinase interactome.

KRT14 KRT17 PSMD1 HIPK3 KMT2C AP2B1 SH3D19 RAPGEF2 MAP2K5 SOS1

9.50e-064861231020936779
Pubmed

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.

KRT9 KRT14 SAMD9 IPO7 KRT17 LSG1 PPFIBP1 KRT84 KRT85 POLR2E GTF3C5 GTF3C3 THOC5 WTAP AP2B1 ASCC3

9.65e-0612571231636526897
Pubmed

Inhibition of calpain 1 restores plasma membrane stability to pharmacologically rescued Phe508del-CFTR variant.

CUL2 KRT9 KRT14 KRT17 KRT81 KRT84 KRT85 KRT86 AP2B1 EXOC4

9.85e-064881231031324722
Pubmed

Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.

IPO5 KRT9 KRT14 IPO7 KRT17 LSG1 PPFIBP1 KRT85 UBR4 POLR2E PSMD1 AP1B1 AP2B1 EXOC2 NIPBL TARBP1 VCPIP1

1.05e-0514151231728515276
Pubmed

BerEp4, cytokeratin 14, and cytokeratin 17 immunohistochemical staining aid in differentiation of basaloid squamous cell carcinoma from basal cell carcinoma with squamous metaplasia.

KRT14 KRT17

1.24e-052123224168496
Pubmed

A missense mutation in the type II hair keratin hHb3 is associated with monilethrix.

KRT83 KRT86

1.24e-052123215744029
Pubmed

Protein-altering germline mutations implicate novel genes related to lung cancer development.

KIAA0930 ATM

1.24e-052123232393777
Pubmed

Loss of ATRX suppresses ATM dependent DNA damage repair by modulating H3K9me3 to enhance temozolomide sensitivity in glioma.

ATRX ATM

1.24e-052123229378238
Pubmed

Three cDNA sequences of mouse type I keratins. Cellular localization of the mRNAs in normal and hyperproliferative tissues.

KRT14 KRT17

1.24e-05212322433272
Pubmed

A variable monilethrix phenotype associated with a novel mutation, Glu402Lys, in the helix termination motif of the type II hair keratin hHb1.

KRT81 KRT86

1.24e-05212329665406
Pubmed

An ataxia-telangiectasia-mutated (ATM) kinase mediated response to DNA damage down-regulates the mRNA-binding potential of THOC5.

THOC5 ATM

1.24e-052123221937706
Pubmed

A new mutation in the type II hair cortex keratin hHb1 involved in the inherited hair disorder monilethrix.

KRT81 KRT86

1.24e-05212329402962
Pubmed

Saikosaponin-d inhibits proliferation by up-regulating autophagy via the CaMKKβ-AMPK-mTOR pathway in ADPKD cells.

CAMKK2 MTOR

1.24e-052123229675630
Pubmed

Regulation of canonical transient receptor potential isoform 3 (TRPC3) channel by protein kinase G.

TRPC3 PRKG1

1.24e-052123214983059
Pubmed

E-NTPDase and E-ADA activities are altered in lymphocytes of patients with indeterminate form of Chagas' disease.

ENPP1 ENTPD1

1.24e-052123222846899
Pubmed

Keratin 17 promotes epithelial proliferation and tumor growth by polarizing the immune response in skin.

KRT14 KRT17

1.24e-052123220871598
Pubmed

Screening diagnostic biomarkers of OSCC via an LCM-based proteomic approach.

KRT14 KRT17

1.24e-052123230066921
Pubmed

NPP1 is responsible for potent extracellular ATP hydrolysis as NTPDase1 in primary cultured murine microglia.

ENPP1 ENTPD1

1.24e-052123229516286
Pubmed

Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes.

IPO5 KRT9 KRT14 KRT17 UBR4

1.26e-0584123529563501
Pubmed

Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.

HJV IPO5 RNASEH2B CAB39 ATRX SZT2 UBR4 UNC13D SPG11 NCAPG2 DICER1 RLF KMT2C ULK2 NIPBL SOS1

1.88e-0513271231632694731
Pubmed

∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.

TBC1D9B IPO8 IPO7 UBR4 POLR2E PSMD1 AP1B1 MTOR LTN1 MX2 EXOC4

1.99e-056471231126618866
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

GCFC2 ATRX ARFGEF2 PSMD1 WTAP FAM13A ATM EXOC2 SNAPC4 NIPBL VCPIP1 SOS1

2.05e-057741231215302935
Pubmed

Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.

CAB39 ATRX PPFIBP1 POLR2E DICER1 HIPK3 CAMKK2 LATS2 AP1B1 AP2B1 PRKG1 MAP2K5 SOS1

2.15e-059101231336736316
Pubmed

DDX24 promotes metastasis by regulating RPL5 in non-small cell lung cancer.

KRT9 KRT14 KRT17 KRT83 KRT84 KRT85 AP2B1

2.33e-05238123735864588
Pubmed

Comprehensive analysis of keratin gene clusters in humans and rodents.

KRT81 KRT83 KRT86

2.34e-0516123315085952
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

IPO7 LSG1 UBR4 POLR2E PSMD1 FASTKD2 NCAPG2 GTF3C5 GTF3C3 RLF AP2B1 LTN1 EXOC2 ASCC3 NIPBL EXOC4

2.38e-0513531231629467282
Pubmed

Shotgun proteomics reveals specific modulated protein patterns in tears of patients with primary open angle glaucoma naïve to therapy.

KRT9 KRT81 KRT83 KRT85 KRT86

2.41e-0596123523580065
Pubmed

Quantitative Proteomics of the SMAD (Suppressor of Mothers against Decapentaplegic) Transcription Factor Family Identifies Importin 5 as a Bone Morphogenic Protein Receptor SMAD-specific Importin.

IPO5 IPO7 GTF3C5 KMT2C

2.57e-0548123427703004
Pubmed

Dlx3 is a crucial regulator of hair follicle differentiation and cycling.

KRT14 KRT17 KRT85

3.39e-0518123318684741
Pubmed

Withdrawal of essential amino acids increases autophagy by a pathway involving Ca2+/calmodulin-dependent kinase kinase-β (CaMKK-β).

CAMKK2 MTOR

3.71e-053123223027865
Pubmed

Small interfering RNAs against the TAR RNA binding protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency virus type 1 long terminal repeat expression and viral production.

DICER1 TARBP1

3.71e-053123217360756
Pubmed

Immunohistochemical staining patterns of cytokeratins 13, 14, and 17 in oral epithelial dysplasia including orthokeratotic dysplasia.

KRT14 KRT17

3.71e-053123224471966
Pubmed

Characterization of the TRBP domain required for dicer interaction and function in RNA interference.

DICER1 TARBP1

3.71e-053123219422693
Pubmed

Protein kinase C can inhibit TRPC3 channels indirectly via stimulating protein kinase G.

TRPC3 PRKG1

3.71e-053123216331690
Pubmed

Ileal neuroendocrine tumors show elevated activation of mammalian target of rapamycin complex.

ATRX MTOR

3.71e-053123225439321
Pubmed

Sequence data and chromosomal localization of human type I and type II hair keratin genes.

KRT81 KRT86

3.71e-05312327556444
Pubmed

ATM protein physically and functionally interacts with proliferating cell nuclear antigen to regulate DNA synthesis.

MTOR ATM

3.71e-053123222362778
Pubmed

Preferential utilization of Imp7/8 in nuclear import of Smads.

IPO8 IPO7

3.71e-053123218519565
Pubmed

Keratin 16 expression defines a subset of epithelial cells during skin morphogenesis and the hair cycle.

KRT14 KRT17

3.71e-053123212445204
Pubmed

Aberrant CD8+ T-cell responses and memory differentiation upon viral infection of an ataxia-telangiectasia mouse model driven by hyper-activated Akt and mTORC1 signaling.

MTOR ATM

3.71e-053123221641396
Pubmed

ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS.

MTOR ATM

3.71e-053123220160076
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

KIAA0930 TBC1D9B SZT2 UBR4 ARFGEF2 PCNX2 KMT2C TNRC18 LATS2 MTOR ULK4 SNAPC4 IL17RD ULK2

3.81e-0511051231435748872
Pubmed

PERP regulates enamel formation via effects on cell-cell adhesion and gene expression.

KRT81 KRT83 KRT86

4.01e-0519123321285247
Pubmed

Suppression of DDX39B sensitizes ovarian cancer cells to DNA-damaging chemotherapeutic agents via destabilizing BRCA1 mRNA.

KRT14 KRT17 KRT84 KRT86 THOC5

4.06e-05107123532989256
Pubmed

K48- and K63-linked ubiquitin chain interactome reveals branch- and length-specific ubiquitin interactors.

CUL2 UBR4 USP25 ERGIC2 NCAPG2 GTF3C3 AP2B1 ABRAXAS1 ASCC3 MAP2K5

6.00e-056041231038803224
Pubmed

C16orf72/HAPSTR1 is a molecular rheostat in an integrated network of stress response pathways.

IPO5 IPO8 IPO7 PSMD1 AP1B1

6.75e-05119123535776542
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

KIAA0930 TBC1D9B RTEL1 PPFIBP1 THOC5 TNRC18 LTN1 PLCH1 EXOC4

6.78e-05493123915368895
Pubmed

A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathies.

KRT14 KRT17 KRT81 KRT83 KRT85 KRT86 VCPIP1

7.13e-05284123729459677
Pubmed

Identifying biological pathways that underlie primordial short stature using network analysis.

IPO5 KRT14 IPO7 KRT17 KRT84 KRT86 POLR2E PSMD1 DICER1 GTF3C5 HOOK3 ASCC3 NIPBL

7.17e-0510241231324711643
Pubmed

An aPKC-exocyst complex controls paxillin phosphorylation and migration through localised JNK1 activation.

EXOC2 EXOC4

7.41e-054123219885391
Pubmed

Association with PAK2 Enables Functional Interactions of Lentiviral Nef Proteins with the Exocyst Complex.

EXOC2 EXOC4

7.41e-054123226350970
Pubmed

Transcriptional activation of a subset of hair keratin genes by the NF-kappaB effector p65/RelA.

KRT81 KRT85

7.41e-054123218021261
Pubmed

The role of cGMP/cGKI signalling and Trpc channels in regulation of vascular tone.

TRPC3 PRKG1

7.41e-054123223832809
Pubmed

Elevated HMGN4 expression potentiates thyroid tumorigenesis.

ATRX ATM

7.41e-054123228186538
Pubmed

ZER1 Contributes to the Carcinogenic Activity of High-Risk HPV E7 Proteins.

CUL2 UBR4

7.41e-054123236346242
Pubmed

Salmonella-directed recruitment of new membrane to invasion foci via the host exocyst complex.

EXOC2 EXOC4

7.41e-054123220579884
Pubmed

Association of epidermal growth factor receptors with coated pit adaptins via a tyrosine phosphorylation-regulated mechanism.

AP1B1 AP2B1

7.41e-05412327534311
InteractionGPR17 interactions

TBC1D9B IPO8 PPFIBP1 ARFGEF2 SPG11 HOOK3 MTOR LTN1 ATM EXOC2 TARBP1 EXOC4

1.53e-0728312212int:GPR17
InteractionCOMTD1 interactions

CAB39 TBC1D9B IPO8 IPO7 PPFIBP1 NCAPG2 HOOK3 MTOR EXOC2 EXOC4

3.89e-0720012210int:COMTD1
InteractionP2RY6 interactions

IPO5 TBC1D9B IPO8 IPO7 UBR4 POLR2E PSMD1 DICER1 PTPRJ MTOR LTN1 EXOC2 EXOC4

6.19e-0738512213int:P2RY6
InteractionKRT19 interactions

KRT14 KRT17 KRT81 KRT83 KRT84 KRT85 KRT86 CCDC77 HOOK3 KIF15 EXOC4

1.18e-0628212211int:KRT19
InteractionFPR1 interactions

TBC1D9B IPO8 ARFGEF2 SPG11 ERGIC2 MTOR ATM EXOC2

3.16e-061471228int:FPR1
InteractionKRT16 interactions

CUL2 KRT17 KRT81 KRT83 KRT84 KRT85 KRT86 ARFGEF2 WTAP

3.20e-061971229int:KRT16
InteractionKRT27 interactions

CUL2 KRT17 KRT81 KRT83 KRT85 KRT86 HOOK3 CCBE1 EXOC4

3.92e-062021229int:KRT27
InteractionLRRC31 interactions

IPO5 KRT9 KRT14 IPO7 ARFGEF2 DICER1 MTOR LTN1 ASCC3

4.43e-062051229int:LRRC31
InteractionCFTR interactions

IPO5 CUL2 KRT9 TBC1D9B KRT14 IPO8 IPO7 KRT17 KRT81 KRT84 KRT85 KRT86 UBR4 POLR2E PSMD1 FASTKD2 AP1B1 AP2B1 MTOR ABRAXAS1 LTN1 PRKG1 MX2 EXOC4

7.69e-06148012224int:CFTR
InteractionTNFSF13B interactions

IPO8 IPO7 PPFIBP1 NCAPG2 HOOK3 MTOR EXOC2

8.01e-061191227int:TNFSF13B
InteractionOFD1 interactions

IPO5 KRT81 KRT83 KRT86 POLR2E CCDC77 LATS2 AP2B1 POC5 SNAPC4 EXOC4

8.61e-0634712211int:OFD1
InteractionKRT76 interactions

CUL2 KRT14 KRT17 KRT84 KRT86 TSGA10

1.20e-05841226int:KRT76
InteractionPCM1 interactions

IPO5 KRT14 KRT81 KRT83 KRT86 LRRC49 CCDC77 HOOK3 LATS2 KIF15 POC5 EXOC4

1.31e-0543412212int:PCM1
InteractionEFNA4 interactions

KRT9 KRT14 KRT17 KRT83 KRT85 NR6A1 ATM TARBP1 SOS1

1.52e-052391229int:EFNA4
InteractionIQCB1 interactions

CAB39 KRT9 KRT14 IPO7 KRT17 ARFGEF2 IRAK2 LATS2 LTN1 SNAPC4 EXOC4

1.57e-0537012211int:IQCB1
InteractionTRIM52 interactions

CUL2 RTEL1 NCAPG2 GTF3C3 HOOK3 ASCC3 SNAPC4

1.66e-051331227int:TRIM52
InteractionGPR182 interactions

IPO8 ARFGEF2 SPG11 ERGIC2 ACY1 NCAPG2 MTOR LTN1 ATM EXOC2 TARBP1 EXOC4

2.09e-0545512212int:GPR182
InteractionKRT14 interactions

CUL2 KRT14 KRT17 KRT81 KRT84 KRT85 KRT86 WTAP

2.24e-051921228int:KRT14
InteractionVIM interactions

TBC1D9B KRT14 GCFC2 KRT17 KRT84 UBR4 TSGA10 PSMD1 NIF3L1 THOC5 WTAP CAMKK2 KIF15 B3GNT2 ASCC3 MAP2K5

2.81e-0580412216int:VIM
InteractionKRT37 interactions

KRT81 KRT83 KRT85 KRT86 HOOK3 VCPIP1

3.26e-051001226int:KRT37
InteractionSLX4 interactions

IPO8 IPO7 ATRX RTEL1 CCDC77 NCAPG2 GTF3C5 GTF3C3 MLH3 AP1B1 AP2B1 ASCC3 NIPBL

4.40e-0557212213int:SLX4
InteractionDUXAP9 interactions

SAMD9 ULK4 ULK2

4.58e-05121223int:DUXAP9
InteractionVCP interactions

IPO5 CUL2 CAB39 KRT9 TBC1D9B KRT14 IPO7 KRT17 ATRX KRT81 PPFIBP1 UBR4 ARFGEF2 PSMD1 DICER1 GTF3C5 GTF3C3 AP1B1 AP2B1 MTOR ANXA10 VCPIP1

4.61e-05143512222int:VCP
InteractionNPTN interactions

GCFC2 IPO8 ARFGEF2 SPG11 MTOR LTN1 ATM EXOC2 TARBP1

4.98e-052781229int:NPTN
InteractionMTMR4 interactions

CUL2 NCAPG2 HIPK3 HOOK3 AP1B1 AP2B1 EXOC4

5.02e-051581227int:MTMR4
InteractionKRT25 interactions

KRT81 KRT83 KRT85 KRT86

5.79e-05351224int:KRT25
InteractionEPS15 interactions

KRT9 KRT14 KRT17 KRT83 KRT85 KRT86 AP1B1 AP2B1

5.89e-052201228int:EPS15
InteractionSIGLECL1 interactions

TBC1D9B IPO8 IPO7 ARFGEF2 AP1B1 LTN1

6.48e-051131226int:SIGLECL1
InteractionKRT13 interactions

CUL2 KRT17 KRT81 KRT85 HOOK3 CEP57

7.50e-051161226int:KRT13
InteractionKRT8 interactions

KRT14 IPO8 KRT17 LSG1 KRT84 LRRC49 UBR4 CCDC77 KIF15 LTN1 CEP57

7.72e-0544112211int:KRT8
InteractionKRT36 interactions

KRT81 KRT83 KRT85 KRT86 CCBE1

8.64e-05741225int:KRT36
InteractionZUP1 interactions

IPO5 KRT9 KRT14 KRT17 SZT2 UBR4 MTOR

9.22e-051741227int:ZUP1
InteractionKRT15 interactions

KRT81 KRT83 KRT84 KRT85 KRT86 NIF3L1 CEP57

1.06e-041781227int:KRT15
InteractionGRB2 interactions

ACAP1 KRT9 KRT14 KRT17 KRT81 KRT83 KRT85 KRT86 UBR4 NIF3L1 HIPK3 PTPRJ AP2B1 SH3D19 SOS1

1.08e-0480612215int:GRB2
InteractionDUSP2 interactions

IPO5 UBR4 DICER1 LTN1 ASCC3

1.33e-04811225int:DUSP2
InteractionCIB2 interactions

RTEL1 GTF3C5 GTF3C3 B3GNT2 ASCC3

1.33e-04811225int:CIB2
InteractionPNKD interactions

IPO8 IPO7 PPFIBP1 NR6A1 DICER1 AP1B1

1.53e-041321226int:PNKD
InteractionCDX2 interactions

IPO8 IPO7 ATRX THOC5 ATM

1.76e-04861225int:CDX2
InteractionSQSTM1 interactions

IPO5 CUL2 IPO7 ENPP1 NIF3L1 FASTKD2 CCDC77 GTF3C3 AP2B1 MTOR B3GNT2 DNAI2 ULK4 ASCC3 RAPGEF2 MAP2K5 ULK2 NIPBL EXOC4

1.95e-04125712219int:SQSTM1
InteractionLEFTY1 interactions

WTAP MTOR

2.16e-0441222int:LEFTY1
InteractionIMPDH2 interactions

IPO5 CUL2 LRRC49 UBR4 PSMD1 KIF15 INTS13 SH3D19 ASCC3 EXOC4

2.40e-0442012210int:IMPDH2
InteractionTPGS2 interactions

LRRC49 UBR4 LTN1

2.66e-04211223int:TPGS2
InteractionKIR2DL4 interactions

TBC1D9B IPO8 IPO7 LTN1 EXOC2

2.67e-04941225int:KIR2DL4
InteractionCTDP1 interactions

POLR2E ARFGEF2 NCAPG2 LTN1 ATM EXOC2 TARBP1

2.69e-042071227int:CTDP1
InteractionOPALIN interactions

IPO8 ARFGEF2 NCAPG2 MTOR LTN1 ATM TARBP1

2.85e-042091227int:OPALIN
InteractionIFFO1 interactions

ACAP1 KRT81 KRT86 LATS2

3.20e-04541224int:IFFO1
InteractionNICN1 interactions

LRRC49 SANBR LTN1

3.51e-04231223int:NICN1
InteractionH3C1 interactions

IPO5 RNASEH2B ATRX CDIN1 UBR4 GTF3C5 GTF3C3 RLF KMT2C TNRC18 PIEZO2 AP2B1 ATM NIPBL TARBP1

3.59e-0490112215int:H3C1
InteractionSSX2IP interactions

IPO8 IPO7 LRRC49 NIF3L1 HOOK3 LATS2 POC5 VCPIP1

3.72e-042881228int:SSX2IP
InteractionC9orf78 interactions

IPO5 CUL2 IPO7 PSMD1 GTF3C5 THOC5 AP1B1 AP2B1 INTS13 LTN1 EXOC2 EXOC4

3.85e-0462012212int:C9orf78
InteractionUBC interactions

CUL2 UBR4 USP25 PSMD1 USP44 KIF15 AP2B1 ABRAXAS1 ASCC3 VCPIP1

3.86e-0444612210int:UBC
InteractionSASS6 interactions

RTEL1 KRT83 LRRC49 UBR4 CCDC77 TARBP1

4.18e-041591226int:SASS6
InteractionHTR6 interactions

IPO8 MTOR ATM EXOC2

4.21e-04581224int:HTR6
InteractionKRT6A interactions

CUL2 KRT14 KRT17 KRT84 TSGA10 WTAP

4.32e-041601226int:KRT6A
InteractionKRT39 interactions

KRT81 KRT83 KRT85 KRT86

4.50e-04591224int:KRT39
InteractionBSG interactions

IPO5 GCFC2 IPO8 IPO7 ARFGEF2 NCAPG2 AP2B1 MTOR ATM EXOC2 TARBP1 EXOC4

4.51e-0463112212int:BSG
InteractionCEP128 interactions

IPO8 LRRC49 CCDC77 LATS2 AP2B1 POC5 ASCC3 EXOC4

4.57e-042971228int:CEP128
InteractionGPR45 interactions

TBC1D9B IPO8 SPG11 ERGIC2 NCAPG2 MTOR ATM EXOC2

4.88e-043001228int:GPR45
Cytoband12q13

KRT81 KRT83 KRT84 KRT85 KRT86

1.44e-0671123512q13
CytobandEnsembl 112 genes in cytogenetic band chr12p11

IPO8 PPFIBP1 ERGIC2 INTS13

8.40e-05851234chr12p11
GeneFamilyKeratins, type II

KRT81 KRT83 KRT84 KRT85 KRT86

8.62e-0827765609
GeneFamilyX-linked mental retardation|RNA helicases

ATRX DICER1 ASCC3

1.15e-05117631168
GeneFamilyArmadillo repeat containing|Importins

IPO5 IPO8 IPO7

5.57e-0518763596
GeneFamilyKeratins, type I

KRT9 KRT14 KRT17

2.17e-0428763608
GeneFamilyExocyst complex

EXOC2 EXOC4

6.16e-0497621055
GeneFamilyDNA helicases

RTEL1 ASCC3

2.28e-03177621167
CoexpressionAtlasfacebase_RNAseq_e10.5_Emin_LatNas_2500_K3

GCFC2 IPO8 IPO7 ATRX RTEL1 LRRC49 SANBR TSGA10 ARFGEF2 CCDC77 DICER1 HOOK3 KIF15 INTS13 CCBE1 ABRAXAS1 ATM RAPGEF2 CEP57 NIPBL SOS1

5.37e-06125711821facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlasFacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1

CAB39 IPO7 EFCAB6 ATRX CDIN1 USP25 FASTKD2 RLF KIF15 RAPGEF2 CEP57 NIPBL

1.20e-0546911812Facebase_RNAseq_e8.5_Floor Plate_2500_K1
CoexpressionAtlasfacebase_RNAseq_e10.5_Emin_LatNas_2500

GCFC2 IPO8 IPO7 ATRX RTEL1 LRRC49 SANBR TSGA10 ARFGEF2 CCDC77 DICER1 HOOK3 KIF15 INTS13 CCBE1 ABRAXAS1 ATM RAPGEF2 CEP57 NIPBL SOS1

4.99e-05145911821facebase_RNAseq_e10.5_Emin_LatNas_2500
ToppCelldroplet-Tongue-nan-24m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KRT81 ENPP1 KRT83 KRT84 KRT85 KRT86 CAMKK2

1.64e-081041237a4ae3cae44aac8b6e0d14896f9acab44f0cc97c4
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

PPFIBP1 TRPC3 PIEZO2 FAM13A CCBE1 SH3D19 PRKG1

9.06e-071871237a9316e2818217ec5feae9cf8816f7249803caee6
ToppCellIPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class

EFCAB6 ARMC3 TSGA10 DNAI2 ULK4 PLCH1 DTHD1

1.12e-061931237ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCell3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ACAP1 KRT81 ENPP1 KRT83 KRT86 UNC13D ENTPD1

1.12e-061931237afdf92ecace145407d57192dde5d0dac0bc37ee9
ToppCellNS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

EFCAB6 ARMC3 LRRC49 DYDC2 DNAI2 PLCH1 DTHD1

1.16e-0619412371ae8a10e508e672e6677f0e3c986ac30d05adeb3
ToppCell3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

EFCAB6 ARMC3 SANBR TSGA10 DNAI2 ULK4 DTHD1

1.16e-0619412374a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCellcontrol-Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

KIAA0930 UBR4 HIPK3 TNRC18 CAMKK2 FAM13A ENTPD1

1.42e-062001237b5d197472799cc61d7497faed91ac2564ae4930a
ToppCelldroplet-Limb_Muscle-MUSCLE-30m-Lymphocytic-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GCFC2 RTEL1 TRPC3 UNC13D ULK4 PRKG1

6.62e-061651236475905d608fac628960188ae4a18010b8097417e
ToppCelldroplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KRT14 KRT17 ENPP1 ACY1 CCBE1 ANXA10

6.62e-061651236622aca1d49bd8c917b131e4f4959d9dba411d22b
ToppCelldroplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KRT14 KRT17 ENPP1 ACY1 CCBE1 ANXA10

7.09e-0616712363c06894fc6177f3c204094719904da42f08b9af8
ToppCell5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

EFCAB6 ARMC3 LRRC9 DNAI2 ULK4 DTHD1

7.59e-061691236fba841664939c771881ba97f14ef1df6635c04ff
ToppCellEntopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Otx2_(ventral_lateral_geniculate_nucleus,_magnocellular_part_(VLGMC)?)--|Entopeduncular / BrainAtlas - Mouse McCarroll V32

DNHD1 MROH5 KIF15 CCBE1 TERB1

1.09e-051051235c7528276fee8f6d2cb4639069bc87413b0288025
ToppCellEntopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Otx2_(ventral_lateral_geniculate_nucleus,_magnocellular_part_(VLGMC)?)|Entopeduncular / BrainAtlas - Mouse McCarroll V32

DNHD1 MROH5 KIF15 CCBE1 TERB1

1.09e-0510512357bcf3345a21a1ade717128be127e9fe12ae40011
ToppCellEntopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Otx2_(ventral_lateral_geniculate_nucleus,_magnocellular_part_(VLGMC)?)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32

DNHD1 MROH5 KIF15 CCBE1 TERB1

1.09e-05105123562e89b92bb8c5187ab0205aebd018b4178710bb0
ToppCell3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ACAP1 KRT81 ENPP1 KRT86 UNC13D ENTPD1

1.35e-05187123642b20d7f0a4f9195b3d71dc0e089b5e0914ebcbb
ToppCell10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue

EPG5 RLF KMT2C FAM13A RAPGEF2 NIPBL

1.39e-051881236ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCelldroplet-Tongue-Unstain-18m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KRT14 KRT17 KRT81 KRT84 KRT85 KRT86

1.43e-0518912367ee9b00a8bd46f2da9218623bb2617b2e585f9d5
ToppCellCOPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class

EFCAB6 ARMC3 DNAI2 ULK4 PLCH1 DTHD1

1.43e-0518912363e77883db34722b9ce0a03ea74caefc92dc7feff
ToppCellfacs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CAB39 ATRX UBR4 ITGA9 PIEZO2 ENTPD1

1.57e-0519212361ccc47792edf9ee23501c8e2165d11271636b66a
ToppCellBronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations

NR6A1 PTPRJ PRKG1 RAPGEF2 EXOC4 SOS1

1.76e-051961236ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

EFCAB6 SANBR TSGA10 LRRC9 ULK4 DTHD1

1.81e-05197123674a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCellsystemic_lupus_erythematosus-treated|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

ACAP1 SAMD9 ATRX ERGIC2 ATM MX2

1.87e-0519812368165ff735095c52994fb5057d89be93cc378b7da
ToppCellTracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations

USP25 KMT2C PTPRJ RAPGEF2 EXOC4 SOS1

1.92e-05199123694b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCellLPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

EFCAB6 ARMC3 ADCY2 DYDC2 LRRC9 DTHD1

1.97e-05200123696701a4d57753f5ec0dd5c7550054bbcc946bc5f
ToppCellLPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

EFCAB6 ARMC3 ADCY2 DYDC2 DNAI2 DTHD1

1.97e-0520012364992dbf0514d674017315dbd20d91dfec0c608e9
ToppCellmild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SAMD9 ATRX KMT2C ATM NIPBL MX2

1.97e-05200123612f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell(08)_PNEC-(2)_48hpi|(08)_PNEC / shred by cell type and Timepoint

KRT17 ENPP1 PPFIBP1 PCNX2 INTS15

4.68e-051421235e95d34170f5053678e0dd9793e68d93c03b05822
ToppCellfacs-Aorta-Heart-3m-Mesenchymal-valve_cells|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HJV ENPP1 AIPL1 PRKG1 DTHD1

6.66e-0515312351440f2716fea74e2c3eb2924eba3d63ebd08c997
ToppCellLPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ARMC3 ADCY2 DYDC2 LRRC9 DTHD1

6.87e-0515412359ca71d440c4f87781e6525b8141e7d8d470b6a8e
ToppCellLPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ARMC3 ADCY2 DYDC2 LRRC9 DTHD1

6.87e-05154123558072ce422d09f2de602580325eaac6c4ec6c136
ToppCellLPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ARMC3 ADCY2 DYDC2 LRRC9 DTHD1

7.09e-0515512355f1e2195a6b831e1b636f5cc3a282ca423721822
ToppCellLPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ARMC3 ADCY2 DYDC2 LRRC9 DTHD1

7.09e-0515512350944429459f642a1bcc56edc1ec28aaecde3e2dc
ToppCell390C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

DNHD1 C8orf48 MLH3 PTPRJ SOS1

8.73e-05162123545be019b50e3727fc9d3fad2ff78e74e4f2d746b
ToppCell390C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

DNHD1 C8orf48 MLH3 PTPRJ SOS1

8.73e-051621235fbb0cc2b1434a340dc35058b77c73ea61004c252
ToppCell390C-Lymphocytic-ILC|390C / Donor, Lineage, Cell class and subclass (all cells)

ENPP1 KRT85 KRT86 INTS13 SOS1

9.25e-051641235b0fc63b72162b5cc4d1e0a271a12f3d3ab29398f
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBCC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

SAMD9 KLHL1 ENPP1 CCBE1 MX2

9.52e-0516512357978eefcfc40175e933f7a8b64a5dd1c661dd1ac
ToppCell3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3|GI_small-bowel / Manually curated celltypes from each tissue

ENPP1 KRT83 KRT86 LATS2 PRKG1

9.79e-051661235773673a5d0430640439845b264740bfbbdad0cb2
ToppCellIonocyte-iono-3|World / Class top

DNHD1 RTEL1 ENTPD1 POC5 PLCH1

9.79e-0516612359c4a780f8af46d7552077c7a0ae0ab1b2413e5d4
ToppCell3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like|GI_small-bowel / Manually curated celltypes from each tissue

ENPP1 KRT83 KRT86 LATS2 PRKG1

1.01e-0416712353ae46c6363da76c8e1f5579e6027bf88ed637a44
ToppCell10x5'-Lung-Lymphocytic_T_CD4/8-lo-Trm_Tgd|Lung / Manually curated celltypes from each tissue

DNHD1 KRT81 KRT86 SH3D19 TARBP1

1.01e-041671235dcbcc658082910838c8082d71a64917055086cc4
ToppCelltumor_Lymph_Node_/_Brain-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass

GTF3C3 CCDC7 KIF15 SNAPC4 ULK2

1.04e-0416812358697b40b2ec2cce68ef3beb4792eb3eff29be053
ToppCell3'_v3-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue

ITGA9 ADCY2 AP1B1 ENTPD1 PLCH1

1.06e-041691235241644823e6f949aaf4c671d4579721d7ef6b0e5
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

KLHL1 CDIN1 ITGA9 KIF15 SLC13A5

1.13e-041711235c2dbc439af28d4fabb24d57685b75b2e588819b0
ToppCell5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

KRT14 KRT17 ENPP1 NR6A1 IL17RD

1.13e-041711235121e63ca281ad765d76c2afb3b4d441329b47f81
ToppCellT_cells-CD56_bright_CD16-_NK_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis

KRT81 KRT86 IRAK2 AIPL1 PRKG1

1.16e-041721235980e8b9e1ceeb0dec9eb9ef95c139e5ffe99b6e4
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBCC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

SAMD9 KRT17 ENPP1 C8orf48 CCBE1

1.22e-041741235912a9e892b29d945666fc37c986009c97c668ac8
ToppCellPND07-28-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma|PND07-28-samps / Age Group, Lineage, Cell class and subclass

ARMC3 DYDC2 DNAI2 ULK4 PLCH1

1.22e-041741235f41d05a3703d7092bd3c4a97c15ae13069aaa4ad
ToppCell5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ENPP1 KRT86 IRAK2 UNC13D B3GNT2

1.22e-041741235c0204a0d0a979a489e8d30dc5396e99da14c119c
ToppCellPND07-28-samps-Epithelial-Epithelial-non_alveolar|PND07-28-samps / Age Group, Lineage, Cell class and subclass

ARMC3 DYDC2 DNAI2 ULK4 PLCH1

1.25e-041751235c01a15b2084da4a18f8ff3623f44eb9dfe499f10
ToppCellLPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ITGA9 FAM13A CCBE1 SH3D19 EXOC4

1.32e-041771235b7fee75de7e96924af488a5baa2334711889ae7c
ToppCellLPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

IPO5 GTF3C3 INTS13 PLCH1 MX2

1.32e-0417712352dd6dd5193bda9ba1c6b299ec47890fdc92f88b1
ToppCelldroplet-Limb_Muscle-nan-21m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NR6A1 MTOR DNAI2 ULK4 EXOC2

1.32e-041771235291231b1520c135e92739e201495fe1935efa927
ToppCell368C-Lymphocytic-NK_cells-NK_cell_C|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

RTEL1 ENPP1 PPFIBP1 KRT86 LATS2

1.36e-04178123550bb1f2c6a8d050ff2af217fd76c3b1b7b4a4a69
ToppCellFF-Differ-KC|World / shred by cell class for mouse tongue

KRT81 KRT83 KRT84 KRT85 KRT86

1.39e-0417912351526a130565a97c291a25a7a988089bffc1515c1
ToppCell5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ACAP1 KRT81 KRT83 KRT86 USP44

1.43e-041801235ca7c316027e31559103b2cab1a2c0de993e42e95
ToppCell5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ACAP1 KRT81 KRT83 KRT86 USP44

1.43e-041801235eb26ba86fba26899e54c448afc25382ddc853013
ToppCell3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-NK_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ACAP1 KRT81 KRT83 KRT86 DTHD1

1.51e-041821235feda21c92d30848de70c8b404eaabbca3f5e894d
ToppCelldroplet-Heart-HEART-1m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRPC3 KIF15 KLHL15 DNAI2 PRKG1

1.51e-041821235c84f44391932080df31c8765e363c3dff64b2bd1
ToppCell3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ACAP1 KRT81 ENPP1 KRT83 KRT86

1.54e-041831235d4a558bc0b8e11be195a7da1468ab38eb477117d
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

OTOA EFCAB6 PIEZO2 CCBE1 PLCH1

1.58e-0418412352cbed6462fea2622871bb7e49b0df3d984239281
ToppCell343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)

TBC1D9B USP25 EPG5 ULK2 VCPIP1

1.58e-0418412352c2125b8030af83f7a6d59a7102d4de8e0ac1988
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

OTOA EFCAB6 PIEZO2 CCBE1 PLCH1

1.58e-041841235ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

OTOA EFCAB6 PIEZO2 CCBE1 PLCH1

1.58e-0418412352b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

ACAP1 SAMD9 ERGIC2 FAM13A ATM

1.63e-041851235406b52516b26e9fe2c9e768950af447ec7ad5f3e
ToppCellNS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

EFCAB6 ARMC3 LRRC49 DYDC2 DNAI2

1.63e-0418512355e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

ACAP1 SAMD9 ERGIC2 FAM13A ATM

1.63e-041851235f2ebd099c8dfcfaca4298bcdd618c50701a9c2c8
ToppCell3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ACAP1 KRT81 KRT83 KRT86 UNC13D

1.63e-041851235e1fd66f4295056807aa29c0e4ce6b1a79cc8dfcf
ToppCellCiliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id

EFCAB6 ARMC3 DYDC2 DNAI2 DTHD1

1.67e-041861235f72267d533fd0c5280d9741ceee3dd116300a7e4
ToppCellControl-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations)

PIEZO2 CCBE1 SH3D19 ULK4 PRKG1

1.71e-04187123592d468dde81125d51daf7abd4703741abe1ab91c
ToppCellpdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

ITGA9 PTPRJ PRKG1 PLCH1 IL17RD

1.71e-0418712357e376831a11ee72ed87abcdac631ca46ae29c250
ToppCell5'-Adult-SmallIntestine-Hematopoietic-T_cells-gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ACAP1 KRT81 KRT83 KRT86 ENTPD1

1.80e-0418912355c85656f555d91ecc9540faa67717694a4aef92f
ToppCelldroplet-Tongue-nan-3m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KRT81 KRT83 KRT84 KRT85 KRT86

1.84e-041901235251e3a33041023bfc4b547c7eb68cfb8f421636f
ToppCell3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR-_ILC3|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ACAP1 KRT81 ENPP1 KRT83 KRT86

1.84e-041901235af39d2a46d9502cec69a69b7e8ffef78fc8311c3
ToppCellnucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

EFCAB6 ARMC3 DYDC2 DNAI2 DTHD1

1.88e-041911235e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f
ToppCellnucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

EFCAB6 ARMC3 DYDC2 DNAI2 DTHD1

1.88e-0419112359d31c8424d35bdc0c27188b68bfd0f731af3600b
ToppCellnucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

EFCAB6 ARMC3 DYDC2 DNAI2 DTHD1

1.88e-0419112351c528f72c9ef3ef3a850b05e4a9715190832270c
ToppCelldroplet-Tongue-Unstain-18m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KRT14 KRT17 KRT81 KRT84 KRT86

1.93e-04192123545ff9555f9a9fccc650885956005b2e5b4820a56
ToppCelldroplet-Tongue-Unstain|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KRT14 KRT17 KRT81 KRT84 KRT86

1.93e-0419212350f0fae7e1177609eff82fa4452042306297a7103
ToppCell10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue

KRT81 ENPP1 KRT86 LRRC49 PRKG1

1.93e-041921235e16035b3328f9b1b2e28d234c62ba88387540550
ToppCelldroplet-Tongue-Unstain-18m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KRT14 KRT17 KRT81 KRT84 KRT86

1.93e-041921235b198e42a962c4e24ea9faad867ca1255316a5d99
ToppCellIPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class

ARMC3 DYDC2 DNAI2 PLCH1 DTHD1

1.93e-041921235d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11
ToppCellrenal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group

PTPRJ SH3D19 PRKG1 RAPGEF2 EXOC4

1.93e-041921235e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCellControl-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class

EFCAB6 ARMC3 DNAI2 ULK4 DTHD1

1.98e-0419312350e37d454f3735edd936ee9a5f5f516ac3aad400e
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

PIEZO2 CCBE1 SH3D19 ULK4 PRKG1

1.98e-041931235b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCellT_cells-CD56_bright_CD16-_NK_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis

KRT81 ENPP1 PPFIBP1 KRT86 PRKG1

1.98e-041931235826457e2aafdb61ead8a0a44d8cf9088d310684b
ToppCellPCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

PIEZO2 LATS2 CCBE1 SH3D19 PRKG1

1.98e-041931235cf3cbf79ccd34ddcf06ec6194a18a7afd7f91f39
ToppCellASK440-Epithelial-Ciliated|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq

ARMC3 TSGA10 DYDC2 DNAI2 DTHD1

1.98e-041931235a0baa8be6f590b2031fede22be588715ae458e93
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

PPFIBP1 TRPC3 PIEZO2 CCBE1 PRKG1

2.03e-041941235b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

IPO5 KRT81 KRT86 UBR4 NCAPG2

2.03e-0419412355031f324628ff12a33e84cc52157be4786e0961d
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

ADCY2 PIEZO2 CCBE1 SH3D19 PRKG1

2.03e-04194123599577a5a631e607b5abe7a1b0d8d6a5eabe50196
ToppCellControl-Epithelial-Ciliated|World / Disease state, Lineage and Cell class

ARMC3 DYDC2 DNAI2 PLCH1 DTHD1

2.03e-041941235958e648138676d46698090b4046cb484083ae449
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

TRPC3 PIEZO2 CCBE1 SH3D19 PRKG1

2.03e-041941235a3e5a15cf6c1361207f661ee15eb634f77daf1cb
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

ADCY2 PIEZO2 CCBE1 SH3D19 PRKG1

2.07e-04195123570387a62f121f8c374dba1aca9ab65cfed6a0b10
ToppCellIPF-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class

PPFIBP1 NR6A1 ITGA9 PIEZO2 PRKG1

2.07e-041951235de88e9d22044b4b3e29676ad02b3e9299cc920ad
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

PPFIBP1 TRPC3 PIEZO2 CCBE1 PRKG1

2.07e-0419512350e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCellControl_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type

ARMC3 ADCY2 LRRC9 DNAI2 DTHD1

2.07e-04195123560067b5359174f0d1a8b5748bfc0690762e9e740
ToppCellBronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ADCY2 PIEZO2 CCBE1 ENTPD1 PRKG1

2.07e-041951235f5e91ce20a7ce528dc4c1a968c7bf096bf45c528
ToppCellSevere-NK|Severe / Disease group and Cell class

SAMD9 KRT81 KRT86 LATS2 MX2

2.12e-04196123566130d38b67e51e2385de8a89227759fd137999c
ToppCellPBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters

IPO5 ARFGEF2 AP1B1 ENTPD1 TARBP1

2.12e-04196123509d197b321ff9f13c0672ea059c850845b0dbbd5
ToppCellSevere-NK|World / Disease group and Cell class

SAMD9 KRT81 KRT86 LATS2 MX2

2.18e-0419712351e5fb79385657a467c2d9f942d8cafb8ef7826c9
ComputationalGenes in the cancer module 68.

KRT14 KRT17 KRT85 KRT86

2.09e-0526694MODULE_68
ComputationalKeratin.

KRT14 KRT17 KRT85 KRT86

2.09e-0526694MODULE_298
Drugal-Badry

KRT9 KRT14 KRT17 KRT81 KRT83 KRT84 KRT85 KRT86 POLR2E

2.88e-071651239CID000004545
Drugteleocidin B

KRT9 KRT14 KRT17 KRT81 KRT83 KRT84 KRT85 KRT86

3.54e-071231238CID000072425
Drugsulfur mustard

KRT9 KRT14 KRT17 KRT81 KRT83 KRT84 KRT85 KRT86

5.40e-071301238CID000010461
Drughomocysteine thiolactone

KRT9 KRT14 KRT17 KRT81 KRT83 KRT84 KRT85 KRT86

5.73e-071311238CID000107712
Drugpyriproxyfen

HJV KRT81 KRT83 KRT86

6.63e-06231234CID000091753
DrugAC1L9MJT

KRT9 KRT14 KRT17 KRT81 KRT83 KRT84 KRT85 KRT86

9.95e-061921238CID000448959
DrugBuflomedil hydrochloride [35543-24-9]; Up 200; 11.6uM; HL60; HT_HG-U133A

TSGA10 THOC5 CAMKK2 ENTPD1 DNAI2 SNAPC4 RAPGEF2 VCPIP1

1.16e-0519612381338_UP
DrugPipemidic acid [51940-44-4]; Down 200; 13.2uM; HL60; HT_HG-U133A

ACAP1 FASTKD2 THOC5 HIPK3 AP1B1 MAP2K5 NIPBL VCPIP1

1.16e-0519612383093_DN
DrugS-(+)-ibuprofen [51146-56-6]; Down 200; 19.4uM; MCF7; HT_HG-U133A

KIAA0930 IPO8 RTEL1 ENTPD1 ATM PLCH1 MAP2K5 VCPIP1

1.16e-0519612386471_DN
Drug1-2q

KRT9 KRT14 KRT17 KRT81 KRT83 KRT84 KRT85 KRT86 ATM

2.81e-052891239CID000011820
Drugmelicopicine

KRT81 KRT83

2.89e-0521232CID000101253
Drugtebuquine

KRT81 KRT83

2.89e-0521232CID000071991
Drug3,5-di-O-galloylquinic acid

KRT81 KRT83

2.89e-0521232CID000460896
DrugVelcade (bortezomib

KRT9 KRT14 KRT17 KRT81 KRT83 KRT84 KRT85 KRT86 PSMD1 MTOR

3.67e-0537412310CID000093860
DrugMetaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Up 200; 7.6uM; HL60; HT_HG-U133A

RTEL1 PPFIBP1 HIPK3 FAM13A ENTPD1 DNAI2 MX2

4.72e-0517512372485_UP
DrugHb 7

KRT81 KRT83 KRT85

5.36e-05141233CID000128180
DrugCP-9

KRT81 KRT83 SOS1

6.68e-05151233CID000452634
DrugDiphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A

IPO5 SAMD9 ATRX ATM RAPGEF2 CEP57 VCPIP1

8.19e-0519112376020_DN
DrugAstemizole [68844-77-9]; Down 200; 8.8uM; HL60; HG-U133A

KIAA0930 PSMD1 CAMKK2 AP2B1 ATM SNAPC4 RAPGEF2

8.47e-0519212371365_DN
Drugsulfonamide-3

KRT81 KRT83

8.65e-0531232CID009847197
Drugtulipanin

ITGA9 MTOR

8.65e-0531232CID000192918
DrugTiaprofenic acid [33005-95-7]; Down 200; 15.4uM; MCF7; HT_HG-U133A

IPO5 SAMD9 ATRX KRT83 GTF3C5 MAP2K5 MX2

9.03e-0519412374171_DN
DrugCyanocobalamin [68-19-9]; Down 200; 3uM; PC3; HT_HG-U133A

GTF3C5 THOC5 CAMKK2 B3GNT2 PLCH1 MAP2K5 SOS1

9.03e-0519412374572_DN
DrugBiperiden hydrochloride [1235-82-1]; Up 200; 11.4uM; MCF7; HT_HG-U133A

SAMD9 IPO8 KRT83 HIPK3 PRDM12 PLCH1 MAP2K5

9.33e-0519512373321_UP
DrugGSK-3 Inhibitor IX; Up 200; 0.5uM; PC3; HT_HG-U133A

IPO5 SAMD9 RTEL1 ARFGEF2 GTF3C5 AP2B1 VCPIP1

9.63e-0519612376559_UP
DrugChenodiol [474-25-9]; Up 200; 10.2uM; PC3; HT_HG-U133A

GCFC2 THOC5 HIPK3 ENTPD1 ATM SNAPC4 PLCH1

9.63e-0519612377310_UP
DrugChloroquine diphosphate [50-63-5]; Up 200; 7.8uM; PC3; HT_HG-U133A

RNASEH2B IPO8 SZT2 THOC5 B3GNT2 INTS15 ANXA10

9.63e-0519612377251_UP
DrugUTP-NA

ENPP1 POLR2E ADCY2 GTF3C5 GTF3C3 CAMKK2 ENTPD1 SNAPC4 PLCH1 MAP2K5

9.64e-0542012310CID000001181
DrugCQ-S

KRT81 KRT83 B3GNT2

9.90e-05171233CID000072462
DrugProadifen hydrochloride [62-68-0]; Down 200; 10.2uM; MCF7; HT_HG-U133A

CUL2 GTF3C5 HIPK3 CAMKK2 AP1B1 MAP2K5 VCPIP1

1.03e-0419812373446_DN
DrugPhentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; HL60; HT_HG-U133A

ACAP1 DICER1 MTOR INTS15 ATM MAP2K5 NIPBL

1.03e-0419812372362_DN
DrugCarbetapentane citrate [23142-01-0]; Down 200; 7.6uM; MCF7; HT_HG-U133A

ATRX ARFGEF2 PCNX2 MTOR B3GNT2 CEP57 NIPBL

1.03e-0419812372623_DN
DrugIoxaglic acid [59017-64-0]; Up 200; 3.2uM; HL60; HT_HG-U133A

SZT2 RTEL1 TSGA10 FASTKD2 MLH3 FAM13A ENTPD1

1.06e-0419912372966_UP
DrugAntipyrine, 4-hydroxy [1672-63-5]; Up 200; 19.6uM; PC3; HG-U133A

IPO5 TBC1D9B RTEL1 ENPP1 MLH3 NIPBL TARBP1

1.06e-0419912371915_UP
DrugDrofenine hydrochloride [548-66-3]; Down 200; 11.4uM; PC3; HT_HG-U133A

TBC1D9B IPO8 PCNX2 AP2B1 B3GNT2 ANXA10 NIPBL

1.09e-0420012377129_DN
DrugPentoxifylline [6493-05-6]; Up 200; 14.4uM; PC3; HT_HG-U133A

IPO5 KIAA0930 KRT9 TBC1D9B FASTKD2 PCNX2 MAP2K5

1.09e-0420012372127_UP
DrugATBI

KRT81 KRT83 KRT86

1.18e-04181233CID000505862
DiseaseMONILETHRIX

KRT81 KRT83 KRT86

6.73e-0831213158000
DiseaseBeaded hair

KRT81 KRT83 KRT86

6.73e-0831213cv:C0546966
Diseasemonilethrix (is_implicated_in)

KRT81 KRT83 KRT86

6.73e-0831213DOID:0050472 (is_implicated_in)
DiseaseMonilethrix

KRT81 KRT83 KRT86

2.68e-0741213C0546966
DiseaseMalignant neoplasm of breast

NPBWR1 ACAP1 TBC1D9B KRT14 UBR4 ARFGEF2 ACY1 ITGA9 THOC5 EPG5 SLC39A12 HOOK3 MTOR ABRAXAS1 ATM NIPBL

8.44e-06107412116C0006142
DiseaseIntellectual Disability

RNASEH2B ACY1 GTF3C3 KMT2C AP1B1 MTOR CCBE1 KLHL15 ENTPD1 ASCC3

1.63e-0544712110C3714756
Diseasehair disease (is_implicated_in)

KRT81 KRT86

1.67e-0521212DOID:421 (is_implicated_in)
DiseaseHereditary Non-Polyposis Colon Cancer Type 2

MLH3 PTPRJ ATM

6.21e-05191213C1333991
DiseaseColorectal cancer, hereditary nonpolyposis, type 1

MLH3 PTPRJ ATM

6.21e-05191213C2936783
Diseasecancer (implicated_via_orthology)

IPO5 CAB39 ACAP1 LATS2 MTOR ATM NIPBL

1.23e-042681217DOID:162 (implicated_via_orthology)
Diseaseaggressive behavior

SAMD9 ARFGEF2 HIPK3

1.45e-04251213EFO_0003015
DiseaseHereditary Nonpolyposis Colorectal Neoplasms

MLH3 PTPRJ ATM

1.63e-04261213C0009405
DiseaseHereditary non-polyposis colorectal cancer syndrome

MLH3 PTPRJ ATM

1.83e-04271213C1112155
Diseaselung small cell carcinoma (is_implicated_in)

ATRX MTOR ATM

2.04e-04281213DOID:5409 (is_implicated_in)
DiseaseHereditary Nonpolyposis Colorectal Cancer

MLH3 PTPRJ ATM

2.27e-04291213C1333990
Diseasefemale breast cancer (is_implicated_in)

RTEL1 ATM

4.59e-0481212DOID:0050671 (is_implicated_in)
Diseasenevus count, cutaneous melanoma

KIAA0930 RTEL1 ATM MX2

5.46e-04911214EFO_0000389, EFO_0004632
DiseaseAdenoid Cystic Carcinoma

ATRX KMT2C ATM IL17RD

7.79e-041001214C0010606
Diseasebrain volume measurement

TBC1D9B SZT2 RTEL1 KRT86 LRRC49 SLC39A12 PTPRJ CCBE1 EXOC2

7.93e-045951219EFO_0006930
DiseaseHamman-Rich syndrome

RTEL1 FAM13A

1.47e-03141212C0085786
DiseaseKartagener syndrome (implicated_via_orthology)

AP1B1 DNAI2

1.47e-03141212DOID:0050144 (implicated_via_orthology)
Diseasecutaneous melanoma

KIAA0930 RTEL1 ATM MX2

1.58e-031211214EFO_0000389
Diseasecolorectal cancer (is_implicated_in)

DICER1 MLH3 PTPRJ ATM

1.58e-031211214DOID:9256 (is_implicated_in)
DiseaseAdenocarcinoma of lung (disorder)

IPO5 IRAK2 LATS2 ATM SOS1

1.63e-032061215C0152013
Diseaseidiopathic pulmonary fibrosis

RTEL1 FAM13A KIF15

1.67e-03571213EFO_0000768
DiseaseNeoplasm of uncertain or unknown behavior of bladder

MTOR ATM

1.69e-03151212C0496930
DiseaseBenign neoplasm of bladder

MTOR ATM

1.69e-03151212C0154017
DiseaseCarcinoma in situ of bladder

MTOR ATM

1.69e-03151212C0154091
DiseaseKeratoderma, Palmoplantar

KRT9 KRT14

1.93e-03161212C4551675
DiseaseMalignant lymphoma, lymphocytic, intermediate differentiation, diffuse

MTOR ATM

1.93e-03161212C0334634
DiseaseCarcinoma of bladder

MTOR ATM

2.44e-03181212C0699885
Diseaseascending aortic diameter

UNC13D PIEZO2 ENTPD1 ULK4

2.69e-031401214EFO_0021787
Diseaseprimary ciliary dyskinesia (implicated_via_orthology)

AP1B1 DNAI2

2.72e-03191212DOID:9562 (implicated_via_orthology)
Diseasediet measurement, HOMA-B

KLHL1 PCNX2

2.72e-03191212EFO_0004469, EFO_0008111
DiseaseUsual Interstitial Pneumonia

RTEL1 FAM13A

2.72e-03191212C4721509
DiseaseHamman-Rich Disease

RTEL1 FAM13A

2.72e-03191212C4721508
DiseaseFamilial Idiopathic Pulmonary Fibrosis

RTEL1 FAM13A

3.02e-03201212C4721952
DiseaseConventional (Clear Cell) Renal Cell Carcinoma

DNHD1 ACY1 MTOR ATM

3.28e-031481214C0279702
Diseaseadvanced glycosylation end product-specific receptor ligand measurement

OR14J1 FAM13A

3.33e-03211212EFO_0010762
DiseaseIdiopathic Pulmonary Fibrosis

RTEL1 FAM13A

3.33e-03211212C1800706
Diseasehair colour measurement

KIAA0930 KRT17 KRT86 UNC13D NR6A1 EPG5 FAM13A EXOC2

3.91e-036151218EFO_0007822
DiseaseImmunologic Deficiency Syndromes

EPG5 ATM

3.99e-03231212C0021051

Protein segments in the cluster

PeptideGeneStartEntry
NEMYASLQEELKSIC

ABRAXAS1

216

Q6UWZ7
AFQLMQEDCIQKLLY

EPG5

1176

Q9HCE0
EKMINTLILNYCQCL

AIPL1

226

Q9NZN9
QMILCNKSYQQLRLV

ANXA10

196

Q9UJ72
NCMQTDNLELKKLVY

AP2B1

56

P63010
QVLLDAEYKQMQCDF

CCDC7

296

Q96M83
INIDITVAMKCQYVG

ERGIC2

76

Q96RQ1
EMFINAIKQYLCVAL

ARFGEF2

426

Q9Y6D5
AENKCNLLEKQLEYM

CEP57

136

Q86XR8
EKKLSNMYQEQCISL

CCDC77

356

Q9BR77
TVEYICTQQNILFML

CAB39

116

Q9Y376
KLMCELGNVIINQIY

ACAP1

471

Q15027
NCMQTDNLELKKLVY

AP1B1

56

Q10567
VKKNSMECIYNLVQD

ARMC3

166

Q5W041
YMICQSLISVLEEQI

DNHD1

526

Q96M86
QVLIMTCYVALNVLK

DICER1

146

Q9UPY3
IMEHCIKQNNAIDIY

DNAI2

116

Q9GZS0
NMQECIDQKVYQAEV

HJV

226

Q6ZVN8
LMQIQKCELVLIHTY

INTS13

196

Q9NVM9
VLNCQKTIYNLVDME

INTS13

491

Q9NVM9
ELQLLEIMCNYFQEQ

INTS15

71

Q96N11
VKVLCLNYNHIESIM

LRRC9

1141

Q6ZRR7
CEILQKMNITYDNLR

LTN1

1051

O94822
DEELNALQSYCTMKI

C8orf48

116

Q96LL4
DATVAQVLLYQMIKC

OTOA

356

Q7RTW8
VCIQISNDYEAKVAM

POC5

311

Q8NA72
NVYAIIMLTKCVEQG

PTPRJ

1131

Q12913
QAKQDMARQLCEYQE

KRT84

436

Q9NSB2
LIEDYRIKQQQQCAM

KMT2C

3261

Q8NEZ4
LFTVMCRKKQQENIY

IL17RD

316

Q8NFM7
ACLQDSYDNLQEIMK

KIF15

861

Q9NS87
CYVKEMDANKENVIL

LSG1

196

Q9H089
VENVMAKEICQKYLE

IRAK2

446

O43187
ECQNQEYSLLLSIKM

KRT9

431

P35527
LCEAEQEQMRKILYQ

LATS2

636

Q9NRM7
LNMDCIIAEIKAQYD

KRT85

286

P78386
QCLNRYKKMQDTVVL

PPFIBP1

331

Q86W92
TEMLKQEEYQIQQNC

DYDC2

71

Q96IM9
QLRCEMEQQNQEYKI

KRT14

386

P02533
NLELSQIQEIVDCMY

PRKG1

106

Q13976
QKAKQDMACLIREYQ

KRT86

376

O43790
LNLILQKLDYMVTCA

KIAA0930

106

Q6ICG6
ELYQQLNDLEACVMQ

IFNA1;

111

P01562
QINTFCTYLLEQIDM

PCNX2

971

A6NKB5
NIMQVFIYCLEQLST

EXOC2

661

Q96KP1
DDLTNVIQKMICEYS

IPO7

556

O95373
VLQQVDNKFIACLMS

MLH3

1191

Q9UHC1
QKQIMSELEILYKCD

MAP2K5

206

Q13163
QMLKLACSYEFINEI

OR14J1

181

Q9UGF5
YIQMVTALVLQLIQC

NIPBL

1486

Q6KC79
IEIRNKNSYMKLCLQ

LRRC49

666

Q8IUZ0
NIEVYNLMCDLLNLT

ENPP1

566

P22413
MTYIKCARNEQEQNL

PRDM12

161

Q9H4Q4
QKVNEIGIYLTDCME

ENTPD1

96

P49961
AVNCEQKQEYIQAIM

HOOK3

126

Q86VS8
QQHYLDVIKRMLVQC

IPO5

166

O00410
CNKIMAKILENYNTL

FAM13A

216

O94988
DYQLVQHEVLCSMKN

HIPK3

181

Q9H422
QVTEKLQLTYMEETC

ITGA9

541

Q13797
SDQFLNMVCVKLQEY

EXOC4

601

Q96A65
KCQELLNYIMDTVKD

ATM

116

Q13315
LMELALQQTYQDTCN

ADCY2

211

Q08462
YNDVLTKQQMLISCV

ATRX

2391

P46100
QAAMYVQLIEVVKFC

KLHL15

106

Q96M94
LRCEMEQQNQEYKIL

KRT17

356

Q04695
MKIYVENLIDCLNEK

GCFC2

326

P16383
TNYISICKMQEVLEE

EFCAB6

981

Q5THR3
MILTKAQYDEIAQCL

CDIN1

1

Q9Y2V0
TCKEFYQMKQTVLQL

CCBE1

201

Q6UXH8
RIMEFIKENCYQVLT

GIMD1

201

P0DJR0
LLQESNCSQYMEKVL

CUL2

226

Q13617
YRDIMVKVCDINLQS

DTHD1

251

Q6ZMT9
MQDCVQLNQYTLKDE

CAMKK2

156

Q96RR4
EMQECTTQIQYLKQV

WTAP

86

Q15007
QILDSRQVCVQYMKD

SLC13A5

71

Q86YT5
YIIHQEEICSSKLNM

SLC39A12

121

Q504Y0
QKAKQDMACLIREYQ

KRT83

381

P78385
ELMCKLIVAIDQYNT

NPBWR1

106

P48145
ELYQQLNDLEACVMQ

IFNA6

111

P05013
NDDVTNVIQKMICEY

IPO8

556

O15397
NVIQKMICEYSQEVA

IPO8

561

O15397
MEEITQQQLVHDKYC

MTOR

286

P42345
QLCSFQVIKDIMQQL

MROH5

716

Q6ZUA9
QLKVSNEEYACMKAI

NR6A1

381

Q15406
QQEYMTKVLECLQQK

RTEL1

21

Q9NZ71
CLFEDKVATMLQQQY

SZT2

191

Q5T011
TIKVYCQRMQEENIT

POLR2E

86

P19388
VLVMLKQTENNYLEC

SH3D19

441

Q5HYK7
TMKCIVNEYTFLLEQ

SAMD9

1361

Q5K651
IMINILQSCKDLQYH

FASTKD2

381

Q9NYY8
LVKEDNLLMAYQICF

PSMD1

236

Q99460
LNCTQKALMQVVDFL

NIF3L1

211

Q9GZT8
EFLKMDSLVEQCIQY

SANBR

236

Q6NSI8
QYVEELILQLLNMLC

SOS1

46

Q07889
MSLEQDNIKQAIFCY

GTF3C3

226

Q9Y5Q9
KMNQEQFIELCKTLY

TBC1D9B

1021

Q66K14
KNKNNICSYVDLMLV

B3GNT2

361

Q9NY97
AQDMKCVSIQYLEAV

ACY1

111

Q03154
QLNNMDEVCYENVLK

ASCC3

696

Q8N3C0
MQVICQSQLEIYKTI

CHST4

246

Q8NCG5
IKDMLLECFININYI

NCAPG2

206

Q86XI2
LKLMLQQCKTQYELG

SPG11

1606

Q96JI7
YCRILNQVEKNMQKV

RAPGEF2

231

Q9Y4G8
CLVVGLEQYEQMLKT

TNRC18

2921

O15417
LEQQMENLVVCVKYG

RLF

1581

Q13129
YLFNMCLQQLFEVKV

RNASEH2B

51

Q5TBB1
CVIIVCKMLYQLQTI

PIEZO2

991

Q9H5I5
CLMYINDKAQFLIQE

USP25

651

Q9UHP3
QEQAEKEMYSLCLLA

VCPIP1

886

Q96JH7
MNNVTTDYCLDIIKK

PLCH1

246

Q4KWH8
YELQLTQEKIMCLDE

TSGA10

226

Q9BZW7
AEKLIYNCAVEMVQS

ULK2

961

Q8IYT8
CLQLNMVYQEVIQEK

SNAPC4

86

Q5SXM2
MFYQLCDLNVEELQK

GTF3C5

406

Q9Y5Q8
QCYLLQTAMNLLDVE

TARBP1

531

Q13395
KYTCQELQRLMAEIQ

THOC5

56

Q13769
TIVQKCLEIYDMIGQ

UBR4

376

Q5T4S7
NVICQLLSDYKEKQM

POTEG

351

Q6S5H5
LNLLLECLKYQMDNA

TERB1

16

Q8NA31
KFLEVELCYMNTNLV

UNC13D

796

Q70J99
VTDTVVYQMNECQEK

USP44

326

Q9H0E7
MLEESKTLNVNCVDY

TRPC3

46

Q13507
LVACKDSNMELLYEQ

ULK4

1061

Q96C45
KMESYLKQQQLCDVI

KLHL1

201

Q9NR64
QKAKQDMACLIREYQ

KRT81

376

Q14533
QMVFCQDQIYSVVLK

MX2

576

P20592